Consistently, decreased SOCS3 was detected in these mice, suggesting that GCSFR may be able to regulate lipid metabolism and insulin sensitivity via JAK/STAT3 signaling to modulate NAFLD. Here, CSF3R is linked to metabolic dysfunction-associated steatotic liver disease.